Related Experiment Video

Updated: Jun 28, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Use of bone morphogenic protein-7 as a treatment for osteoarthritis

Neil Badlani1, Yasushi Oshima, Rob Healey

  • 1Department of Orthopaedic Surgery, University of California, San Diego, 9500 Gilman Drive, Mail Code 0630, La Jolla, CA 92093-0630, USA.

Clinical Orthopaedics and Related Research
|October 23, 2008
PubMed

Insights

Bone morphogenic protein-7 (BMP-7) treatment reduced cartilage degradation in a rabbit osteoarthritis model. BMP-7 therapy demonstrated potential for protecting articular cartilage in existing osteoarthritis.

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biochemistry

Background:

  • Osteoarthritis (OA) is characterized by articular cartilage breakdown.
  • Bone morphogenic protein-7 (BMP-7) has shown potential chondroprotective effects.
  • The role of BMP-7 in established OA requires further investigation.

Purpose of the Study:

  • To evaluate the efficacy of BMP-7 in reducing cartilage degradation in a preexisting osteoarthritis model.
  • To assess the impact of BMP-7 on key cartilage matrix components and catabolic mediators.

Main Methods:

  • A rabbit anterior cruciate ligament transection (ACLT) model was utilized to induce osteoarthritis.
  • BMP-7 was administered via osmotic pump to the joint four weeks post-ACLT.
  • Cartilage degradation was assessed using Outerbridge scoring and histomorphometry.
  • Gene expression analysis (RT-PCR) of aggrecan, matrix metalloproteinase-3 (MMP-3), and matrix metalloproteinase-13 (MMP-13) was performed.

Main Results:

  • The BMP-7 treated group exhibited reduced cartilage degradation compared to controls (Outerbridge score 1.9 vs. 2.6).
  • Histomorphometry indicated a trend towards less cartilage degradation with BMP-7 treatment.
  • BMP-7 treatment increased aggrecan expression and decreased MMP-3 and MMP-13 expression in cartilage.
  • Synovial tissue in the BMP-7 group showed reduced expression of MMP-3, MMP-13, and aggrecanase.

Conclusions:

  • BMP-7 demonstrates a therapeutic potential to mitigate cartilage degradation in established osteoarthritis.
  • BMP-7 may exert its protective effects by modulating extracellular matrix synthesis and inhibiting catabolic pathways.
  • Further research into BMP-7 as a treatment for OA is warranted.

Related Concept Videos

Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.